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INTRODUCTION
Antimalarial drugs are indispensable components of the global strategy for malaria control and elimination 1 . Clinical treatment failure with artemisinins, drugs characterised by very short serum half-lives in the treated host, has been demonstrated throughout the Greater Mekong subregion [2] [3] [4] [5] [6] [7] , and there is some evidence of decreasing effectiveness of artemisinin combination therapies (ACT) in Africa [8] [9] [10] [11] [12] . Delayed parasite clearance in Southeast Asia has been linked to several mutations in the propeller-encoding domain of the pfkelch13 (K13) gene 6, 13 . However, these mutations have not been observed in parasite populations circulating in Africa, and the function of K13 and its role in resistance remains unclear 9, 11 . Other Plasmodium loci have been shown to contribute to artemisinin susceptibility in laboratory studies, including the P. falciparum homologue of the actin-binding protein Coronin 14 . Given that variants of at least two different proteins modulate parasite survival under artemisinin pressure, understanding of any genetic and cellular factors that affect artemisinin susceptibility is desirable for preservation of ACT efficacy worldwide.
Among other candidate loci, the medium (µ) subunit of the AP-2 adaptin trafficking complex (AP-2µ) was first associated with artemisinin susceptibility by Hunt et al in multi-drug resistant lineages of P. chabaudi, derived by experimental drug selection in rodent hosts 15 . Linkage analysis identified a mutation encoding PcAP-2µ(I568T) in an artemisinin resistant parasite population when compared with sensitive progenitors 16 . While subsequent studies failed to identify an orthologous P.
falciparum AP-2µ(I592T) mutation in human infections, evidence was found for directional selection for a PfAP-2µ(S160N) variant in ACT-treated patients 9 . In vitro over-expression suggested this naturally-occurring PfAP-2µ mutation may impact some drug responses, but its role in artemisinin susceptibility remains unclear 17 . Given the adaptation of the CRISPR-Cas9 system to P. falciparum and new data implicating intracellular traffic in the complex artemisinin resistance phenotype, we set out to clarify the impacts of these mutations on in vitro artemisinin susceptibility and to probe the underlying biology of the AP-2µ protein in the parasite cell.
In virtually all other eukaryotes, adaptin complexes consist of a heterotetramer and mediate endocytosis and post-Golgi inter-compartment vesicular traffic of receptor-bound cargo 18 . Each adaptin complex consists of four subunits: two large (/ and ), one medium (µ), and one small () 19 . In particular, the µ subunit interacts with cargo molecules and vesicular membranes and has important regulatory phosphorylation sites 19, 20 . The AP-2 complex is recognised as participating in clathrin-mediated endocytosis from the plasma membrane to the early endosomal compartment in most eukaryotes 20, 21 . To date there have been no experimental studies of adaptins in P. falciparum or other Apicomplexa, and AP-2 is predicted to be involved in endocytosis of haemoglobin from the host cell in P. falciparum 16, 22, 23 .
Although the mechanism of artemisinin action in the parasite remains elusive, haemoglobin metabolism is believed to activate the endoperoxide bridge in the artemisinin molecule, required for the drug's cytotoxic effect [24] [25] [26] . This process may thus link drug activation to trafficking of haemoglobin into the parasite from the host cell cytoplasm. In vitro artemisinin resistance is currently defined by survival and expansion of parasite cultures after brief drug exposure during the ring stage, mimicking artemisinin pharmacokinetics in vivo 27 . Reports suggest that activated artemisinin induces disseminated oxidative stress and that resistant parasites have enhanced responses to counter the impact of protein damage and redox stresses centred around the endoplasmic reticulum 28, 29 . How resistance-associated factors, including variant K13, Coronin, or AP-2, contribute to these ringstage-specific mechanisms is still under investigation.
Here we have investigated the effect of pfap2mu mutations on artemisinin susceptibility by generating parasite lineages harbouring I592T and S160N PfAP-2µ mutations via Cas9 genome editing. We then explore the biology of the wildtype PfAP-2µ protein, uncovering unexpected divergences from canonical eukaryotic trafficking biology.
RESULTS

A variant of AP-2µ mediates P. falciparum ring-stage survival during artemisinin pressure in vitro
Two single-nucleotide polymorphisms, encoding PcAP-2µ(I568T), identified in P. chabaudi, and PfAP-2µ(S160N), identified in human P. falciparum infections, have been suggested to modulate sensitivity to artemisinin in Plasmodium 9, 16 . Using Cas9 editing, we generated clonal P. falciparum lines endogenously expressing the orthologous I592T and the naturally-occurring S160N PfAP-2µ mutations on the chloroquine-sensitive 3D7 background (Fig. 1A-B ). Transgenic parasites with the integrated mutations were obtained within three weeks of transfection and cloned (Fig. 1B) .
Currently, the only validated in vitro measure of artemisinin susceptibility is the ring stage survival assay (RSA) 27, [30] [31] [32] . Thus, we examined the survival of ring-stage parasite cultures, two clones of each mutant line, to a 4h pulse of 700 nM DHA using a modified RSA pulse protocol first described and validated by Yang et al [32] [33] . Compared to 3D7, the two independent clones harbouring the I592T mutation displayed significantly higher RSA 4h survival rates of 10.3% (P = 0.0011) and 8 .0% (P = 0.0011), respectively, contributing an approximately 4-5-fold increase in RSA survival when compared to wildtype progenitors. Clones harbouring the S160N mutation displayed equivalent survival after the artemisinin pulse when compared to wildtype progenitors. For comparison,
Cambodian clinical isolates harbouring either the circulating R539T or C580Y K13 mutations displayed 28.0% and 17.3% RSA 4h survival in our hands, respectively (Fig. 1D) , contributing 10.6-and 6.5-fold increases in survival, respectively, compared to an isogenic K13 wt Cambodian isolate.
Standard 48hr EC50 estimates for quinine, piperaquine, and mefloquine susceptibility were not affected in clones of either pfap2mu-variant lineage, but we did observe modest, but statistically significant, potentiation (decreased EC50) of lumefantrine and chloroquine in both I592T clones (Fig.   1C ). As previously demonstrated for other artemisinin resistant lineages, 48h EC50 estimates for artemisinin were unchanged in the I592T clones, compared to wildtype progenitors. We also generated a transgenic parasite line expressing the wildtype I592I codon in the context of silent "shield" mutations required for obliterating the Cas9 PAM site in the pfap2mu locus used during I592T editing to confirm the effects observed in the RSA and 48h assays were directly attributable to the I592T SNP. As expected, two clones of this I592I lineage demonstrate equivalent sensitivity in all assays when compared to 3D7. These data demonstrate that AP-2 mutation can confer significant ring-stage protection from artemisinin in an otherwise drug-susceptible P. falciparum strain in vitro.
AP-2 is localised to a cytoplasmic compartment
A mechanistic understanding of I592T-mediated artemisinin resistance first requires knowledge of the biology of the wildtype PfAP-2µ protein.
To generate this information, we sought to characterise the cellular location, essentiality and interactome of this protein. We expected that AP-2µ
would be involved in clathrin-mediated endocytosis from the plasma membrane based on eukaryotic trafficking dogma 19 . Thus, using Cas9 editing, we installed a tandem triple haemagglutinin (3xHA) epitope tag onto the C-terminus of the protein ( Fig. 2A-C ) and examined the localisation of AP-2µ-3xHA by IFA across the asexual lifecycle in two clones (AP-2µ-3xHA_c1 and AP-2µ-3xHA_c2).
AP-2µ-3xHA distribution was similar in both clones, so only the data from AP-2µ-3xHA_c1 are presented. Contrary to our expectations that AP-2µ-3xHA would decorate the parasite plasma membrane, consistent with a role in endocytosis, we observed that, throughout the asexual cycle, AP-2µ localises to additional punctate structures in the parasite cytoplasm (Fig 2D) . In the ring stage, AP-2µ-3xHA typically appears as a single focus, near the parasite plasma membrane. As the cell develops, foci increase in number and localise to a cytoplasmic compartment in trophozoites (Fig.   2D ). During schizogony, the AP-2-labelled structure multiplies and segments into each daughter merozoite (Fig. 2D) . To probe the observed punctate localisation of AP-2µ further, its cellular distribution was examined with respect to a panel of representative organelle markers. However, the distribution of AP-2µ signal did not correlate well with that of the ER, Golgi complex, or the apicoplast during development or with the apical secretory organelles during schizogony (Suppl. Fig.   1 ). When compared with brightfield, a focus of AP-2µ was often in close apposition to the digestive vacuole, but these structures were never observed to overlap (Fig. 2D , middle column).
To better characterise the localisation of AP-2µ, we performed immunoelectron microscopy (immuno-EM) on thin sections of trophozoites expressing AP-2µ-3xHA. In analysis of 66 micrographs of single parasite-infected erythrocytes, gold particles detecting anti-HA antibodies bound to AP-2µ-3xHA were observed at the nuclear membrane and ER (73.8% of micrographs), in vesicles in the cytosol (37.9%), in close proximity to tubular cytosolic structures (93.6%), near the food vacuole (5.8%), and, rarely, at the parasite plasma membrane (4.2%) (Fig 2E, Suppl . Table 1 ).
Immunostaining against the endoplasmic reticulum (ER)-resident protein disulfide isomerase (PDI) suggests that these tubular structures may be cross-sections of distal extensions of the ER (Fig. 2E ).
Co-staining against Rab5B, an effector of endosomal transport, suggests at least some of the cytosolic AP-2µ associates with Rab5B + vesicles (Suppl. Fig. 2 ). Parasites expressing AP-2µ-2xFKBP-GFP showed a similar localisation by immuno-EM (Suppl. Fig. 3 , Suppl. Table 1 ), but GFP fluorescence was too faint to reliably observe in live cells.
Because Plasmodium parasites lack a stacked Golgi apparatus, differentiating the ER and
Golgi by EM is difficult. Therefore, AP-2µ-3xHA parasites were treated with brefeldin A (BFA), a fungal metabolite and fast-acting inhibitor of ER-to-Golgi secretory traffic. Upon stimulation with BFA, proteins localised to, or trafficked via, the Golgi relocalise to the ER. Previous studies examining intracellular traffic in Plasmodium have shown that parasite cultures can be treated with 5 µg/ml BFA for up to 24h while remaining viable 34, 35 . After treating ring stage parasites with 5 µg/ml BFA for 16h, AP-2µ-3xHA staining significantly co-localised with staining observed for plasmepsin V, a luminal ER protease, suggesting AP-2µ is localised to a secretory membrane. AP-2µ and plasmepsin V staining were distinct in solvent-treated controls. (Suppl. Fig. 4 ).
In recent studies, K13 has been localised to conspicuous membranous structures in the cytosol 36 , and these superficially resemble the structures labelled by AP-2µ here (Fig. 2 D, E) . Given the apparent similarity in cellular distribution and the importance in ring-stage artemisinin susceptibility in vitro of both molecules, we hypothesised that AP-2µ and K13 localise to the same cytosolic compartment. We overexpressed an episomally-encoded N-terminal GFP-K13 fusion protein in our AP-2µ-3xHA-expressing line and observed a striking similarity in signal distribution between the K13
and AP-2µ in fixed ring and schizont stages (Fig. 2F) . The GFP-K13 signal resembled what has previously been reported 36 .
PfAP-2µ is required for asexual replication
Given these results demonstrating an unexpected cytoplasmic localisation for AP-2µ, we sought to better characterise the protein's functional importance. Previously results suggested that AP-2µ is required for asexual replication, but its role in asexual development is unclear. Therefore, we deployed the inducible DiCre system described by Collins et al to study the phenotypic effects of conditional pfap2mu knockout (KO) in vitro
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. Specifically, the Cas9 donor constructs described above were modified to install both a loxP site into the 3' UTR immediately after the pfap2mu stop codon and the loxP-containing pfsera2 intron described by Jones et al into the 5' end of the gene, 261
bp into the CDS, such that Cre-mediated excision removes the majority of the coding sequence, including the 3xHA tag. These constructs were transfected into 3D7 parasites constitutively expressing dimerisable Cre recombinase 38 (Fig. 3A) .
Ring stage cultures of the 3D7-AP-2µ-floxed-3xHA parasites were treated with 10 nM rapamycin (rap) in DMSO for 30 min to dimerise the split Cre recombinase and trigger pfap2mu excision. Genomic DNA was extracted 24h after this treatment, and PCR confirmed near-complete excision of the floxed region of pfap2mu (Fig. 3B) , resulting in ablation of AP-2µ protein expression (Fig. 3C ). Daily parasite counts by FACS revealed that induced-KO of pfap2mu prevented parasite replication within a single asexual cycle, without appreciable recovery over multiple cycles (Fig. 3D) ,
showing that pfap2mu is required for asexual replication in vitro. Importantly, the Cre-mediated endogenous pfap2mu KO was fully complemented with an episomally-expressed copy of AP-2µ-GFP under a constitutive promoter ( Fig. 3E-G ; Suppl. Fig. 5 ). These results also support our localisation studies, indicating that disrupting AP-2µ is lethal, and C-terminal AP-2µ tags are thus tolerated by the parasite.
When examined by Giemsa staining, parasites lacking pfap2mu arrest as malformed schizonts (Fig. 3H ). These defective schizonts occupy approximately half of the red cell cytoplasm and contain poorly segmented merozoites compared to wild-type schizonts. Despite the reduced size of schizonts in pfap2mu knockouts, their DNA content is similar to that of fully segmented, egress-blocked schizonts by FACS (Suppl. Fig. 6 ). Rarely, rap-treated parasites were observed to undergo egress and invasion despite the addition of rapamycin and probably represent incomplete excision of pfap2mu across the cultured population. Supporting this, in our PCR amplification of genomic DNA extracted from these rap-treated cultures, a faint 3kb band, indicative of unexcised full-length pfap2mu, was detected ( Fig. 3B ). This phenomenon of incomplete Cre-mediated excision has been reported previously 37 .
PfAP-2µ is required for schizogony
Examining these deformed schizonts by electron microscopy revealed that AP-2µ deletion results in gross morphological defects during schizogony and merozoite biogenesis ( Fig. 3I ; Suppl. 3I ; Suppl. Fig. 6 ). In AP-2µ-KO schizonts, peripheral plasma membranes were consistently poorly preserved during fixation and processing for electron microscopy despite several replicate preparations. These membrane bilayers tended to separate dramatically compared to membranes in wild-type schizonts, and we cautiously attribute this observation to increased membrane fragility in the absence of AP-2.
Additionally, electron micrographs revealed a statistically significant accumulation of lipid bodies in the cytosol of AP-2µ KO schizonts ( Fig. 3I ; Suppl. P<0.0001). Consistent with this, haemozoin crystals were occasionally observed in the schizont cytosol. Wild-type and KO trophozoites appear morphologically equivalent (Suppl. Fig. 6 ), and apicoplasts can be observed in these cells.
Subsequent IFA imaging supported these findings, revealing that pfap2mu is required for the genesis of several membrane-bound organelles (Suppl. Fig. 7) . Specifically, AMA1, RON4, and CDC48, markers of the micronemes, rhoptries, and apicoplast, respectively, are mis-localised by IFA, despite being detectable at normal levels by western blot (Suppl. Fig. 7, 8 ). Despite the apparent mislocalisation of AMA1 and RON4 by immunofluorescence (Suppl. Fig. 7 ), rhoptries and micronemes are visible in some KO schizont EM sections (Fig. 3I) , implying a defect in transport rather than organelle biogenesis. Additionally, in KO schizonts, MSP1 antibody staining is disrupted, suggesting that trafficking to the schizont plasma membrane, which invaginates around the nascent merozoites during schizogony, may be disrupted in the absence of AP-2µ. The parasitophorous vacuole, labelled by EXP2, seems to be largely intact though may have unusual discontinuities in some cells. The ER and cis-Golgi display no obvious abnormalities in cells lacking AP-2µ (Suppl. Fig. 7 ). Overall, it is unlikely that these widespread defects are all directly attributable to AP-2µ function. Instead, this complex phenotype may be the result of knock-on effects of AP-2µ deletion affecting downstream effector molecules.
The AP-2 complex is clathrin-independent and associates with Kelch10
To elucidate some of these possible AP-2µ interacting partners, we immunoprecipitated AP-2µ and performed mass spectrometry. Trophozoite cell lysates of P. falciparum AP-2-3xHA were prepared using cryomilling and detergent lysis, a cell disruption technique shown to preserve labile protein-protein interactions and generate high resolution interactomes in other organisms, though not previously deployed in Plasmodium 39 . Using both Triton-and CHAPS-containing lysis buffers originally derived for the extraction of clathrin-interacting proteins from Trypanosoma species, we lysed frozen trophozoite pellets and performed pulldowns using anti-HA conjugated beads.
As previously discussed, AP-2 is the canonical clathrin-interacting endocytic complex in essentially all other studied eukaryotes, and we expected AP-2µ to interact with clathrin and the other putative AP-2 subunits in P. falciparum. Four adaptor complex subunits were enriched under both lysis conditions tested, demonstrating that the AP-2 complex in P. falciparum comprises subunits annotated in the genome as AP-2, AP-2, AP-2µ (our tagged bait protein), and AP-1, previously predicted to be shared between the AP-1 and AP-2 complexes  ( Fig To validate our interactome, we confirmed that AP-2µ-3xHA copurifies with episomallyexpressed and immunoprecipitated K10-GFP but not similarly expressed cytosolic GFP (Fig. 4D ). We sought to confirm the absence of interacting clathrin by direct IP of CHC from P. falciparum AP-2-3xHA lysates and western blotting with anti-HA antibodies. We were still unable to find evidence that AP-2µ-3xHA co-purifies with immunoprecipitated CHC (Fig. 5D ). Using the same clathrin antibody, first validated on a parasite line expressing PfCHC-2xFKBP-GFP ( Fig. 5A ), we also found that AP-2µ-3xHA and CHC are localised to separate compartments by IFA (Fig. 5E ).
To test robustly the observation that AP-2 does not interact with CHC, we performed a similar IP-MS analysis on a trophozoite preparation of parasites expressing CHC-2xFKBP-GFP. As expected 42 , all AP-1 complex components were enriched in these PfCHC pulldowns, including AP-1/2 as were other trafficking-associated components ( Fig. 5B ; Suppl. Table 4 ). However, no peptides from AP-2 , µ, and  subunits were identified in MS analysis of four replicate pulldowns ( Fig. 5B, 5C ). AP-2 independent clathrin-dependent endocytosis has been demonstrated in African trypanosomes, where the genes encoding the AP-2 subunits are absent, and also suggested in T. cruzi where clathrin does not appear to interact with AP-2, but has never before been demonstrated in Plasmodium. AP-3 complex subunits were also identified but were not enriched compared to controls.
The role of the AP-4 complex is unclear in eukaryotes, but this complex is not believed to interact with clathrin. Consistent with this, we did not detect peptides corresponding to the P. falciparum AP-4 complex. Interestingly, we found peptides corresponding to Sortilin, Vps9, a DnaJ chaperone, and RESA enriched in the clathrin interactome, among other exported and trafficking-related factors.
Collectively these data suggest that retromer, trans-Golgi, and secretory trafficking likely involve clathrin-coated vesicles (Suppl. Table 4 ). Consistent with these diverse active processes, our localisation of PfCHC demonstrates many rapidly-cycling foci decorating the plasma membrane and cytoplasmic structures in live trophozoites ( Fig. 5F ). This dynamic localisation was never observed for AP-2 in our imaging studies. These data support a novel, clathrin-independent role for the AP-2 complex in Plasmodium.
Disruption of trafficking confers high-level artemisinin resistance in vitro
As a first step to explore the mechanism of the AP-2µ(I592T)-mediated artemisinin resistance phenotype reported above, we lastly proposed that disruption of intracellular traffic would increase parasite tolerance to artemisinin exposure. been proposed to interact with EPS15, an AP-2 partner described in other eukaryotes, a homologue of which was identified here as interacting with AP-2 in P. falciparum ( Fig. 4C ; Suppl. Table 3 ). We also clarify that the PfAP-2µ(S160N) mutation currently circulating in African parasite populations does not impact ring-stage artemisinin sensitivity in the 3D7 genetic background.
By interrogating the localisation of epitope-tagged AP-2µ using immunofluorescence and immunoelectron microscopy, we provide evidence that the AP-2 complex is localised to the plasma membrane as well as distinct cytoplasmic foci, likely corresponding to vesicles throughout the cytosol during intra-erythrocytic development. These foci segregate into merozoites during schizogony before being carried into the nascent parasite. By immunoelectron microscopy, we show that these vesicles partially co-label with ER-resident PDI, as well as with Rab5B, a protein associated with the parasite plasma membrane and digestive vacuole as trafficking destinations. Surprisingly, these vesicles also correspond well with K13-labelled structures within the resolution limits of light microscopy, though we find no evidence of direct interaction between the two molecules. Instead, AP-2µ associates with another kelch-type protein, P. falciparum K10, and also with potential trafficking chaperones and regulators.
We demonstrate that the AP-2 complex contains   and  subunits plus a -subunit that supplies both the AP-1 and AP-2 complexes. This promiscuous behaviour has been reported previously in other organisms, where it has functional importance for targeting the vesicular complex to specific membranes 48 . Further work is required to determine if this is also true of  in
Plasmodium. Additionally, we provide the first description of CHC in P. falciparum and find no evidence of interaction or co-localisation with AP-2, despite identifying other adaptor complex subunits in a CHC pulldown. This was surprising because AP-2 is the canonical clathrin adaptin complex of eukaryotes, although a similar result was obtained for AP-2 in T. cruzi 43 . A previous study of AP-1µ in P. falciparum identified CHC as an interacting partner 46 , and we recapitulate this,
showing that all four components of the AP-1 complex immunoprecipitate with CHC. This suggests that despite the shared  subunit, which canonically links the AP complex to clathrin, other subunits or factors may be involved in coat protein selection in Plasmodium falciparum. The coat protein (or proteins) associated with PfAP-2 vesicles remains unknown but may lie among the many proteins of unknown function identified in our AP-2 interactome (Fig. 4 ; Suppl. Table 2 ). Future studies should aim to further define AP-2-and clathrin-mediated traffic in Apicomplexans and establish whether other adaptins perform similarly diverged non-canonical roles, potentially with impacts on drug susceptibility, immune evasion and the basic biology of the parsite cell. It remains to be determined if such AP-2-independent clathrin-trafficking is more widespread, as the presence of such a pathway in two evolutionarily distinct protsists suggests this may be a more general phenomenon.
Further to these unexpected findings, we show conditional AP-2µ deletion causes profound defects in membrane segregation and organellar integrity during schizont maturation, and prevents intra-erythrocytic growth of P. falciparum in vitro. It is difficult to tease out which aspects of the complex observed phenotype are secondary to AP-2µ knockout and which are primary. Colocalisation of µ2 and Rab5B by immunoelectron microscopy may suggest that the observed plasma membrane fragility, lipid droplet accumulation, and disrupted digestive vacuoles are interrelated. AP-2µ KO may disrupt retromer-like trafficking needed to recycle lipid from the digestive vacuole back to the plasma membrane, leading to lipid accumulation near the digestive vacuole and insufficient fatty acids available for growing and segregating membranes during schizogony. This potential role for AP-2 in membrane organisation in schizonts may impact the integrity of apical secretory organelles, as several key factors are mislocalised in nascent merozoites upon AP-2µ KO (Suppl. Fig.   7, 8 ). These observations and the specific directionality of AP-2 traffic require further investigation.
Our data, although supportive of a link between trafficking, K13, and artemisinin susceptibility, can provide no new direct insights into the elusive function of K13 in P. falciparum.
Previous studies have suggested K13 may be a ubiquitin ligase scaffolding factor and associated with PI3P-labeled secretory vesicles in the cell 49, 50 . A general role for K13 in intracellular traffic determined by these studies fits well with our data, but further work is necessary to reconcile those studies with others showing a conflicting role for PI3P 51 and implicating autophagy in modulating artemisinin susceptibility 52 . As a recycling process, autophagy is dependent upon intracellular
trafficking, and we demonstrate that AP-2 deletion clearly affects similar processes.
Interference with intracellular traffic, in our hands via either transient BFA treatment in this study or temperature modulation 33, 46 , induces a profound artemisinin resistance phenotype in genetically wildtype 3D7 parasites. As we show, BFA induces regulatory phosphorylation of eIF2, a hallmark of the cell stress response and globally attenuated protein synthesis, which mechanistically underlies artemisinin resistance. Consistent with this, previous data indicate that similar transient BFA treatments also stall development and translation in Plasmodium ring stages 34 . We interpret these data to indicate that the fidelity of intracellular trafficking is intimately linked with this stress response, and we anticipate that AP-2 mutation mechanistically disrupts the processes observed here. Further studies characterising our AP-2µ(I592T) mutant, in particular those examining membrane organisation, DV integrity, and stress response activation, are planned.
Resistance to artemisinin has long been thought to be multigenic, consistent with our model presented above 14, 53 . So far, laboratory evolution of artemisinin resistance has mostly generated parasites with K13 mutations that are different from those most prevalent in the field, or mutations in other loci altogether, such as the recently-described pfcoronin 6, 14, 47 . Similarly, the AP-2µ(I592T) mutation described in this study has not been observed in human infections. However, using the descriptive characterisation provided here of the wildtype PfAP-2µ molecule as a platform, full characterisation of the I592T variant can now proceed, with the aim of understanding the mechanism by which in vitro artemisinin susceptibility is significantly reduced.
Materials and Methods
Plasmid Design and Construction.
Two plasmids were created for transfecting 3D7 parasites: pL6-AP2µ(I592T)-sgDNA and pL6-AP2µ(I592I)-sgDNA. These constructs utilized the plasmid system described by Ghorbal et al. and encoded the donor sequence carrying the mutation of interest and the guide RNA 54 . The pfap2mu_I592T donor template was created by first amplifying the 5' homology region with primers P1 and P2 and the 3' homology region with primers P3 and P4. These two fragments were assembled by overlap PCR using primers P1 and P4; the resulting fragment was cloned into pL6-eGFP with EcoRI and NcoI. Primers P5 and P6 were annealed to create a dsDNA molecule encoding the sgRNA sequence with 5' and 3' extensions to enable InFusion Cloning (Clontech) into BtgZI-digested pL6.
To create the AP2µ (I592I) donor fragment, primers P2 and P3 mentioned above were replaced with P7 and P8. Primer sequences are provided in Supplementary Table 22 .
Parasite Culture and Generation of Transgenic Parasites
Plasmodium falciparum culture was performed in AB+ red blood cells obtained from the UK National
Blood & Tissue Service, in RPMI supplemented with Albumax II, L-glutamine, and gentamycin, at 5% haematocrit under 5% CO2 conditions at 37ºC, and synchronised using 70% Percoll gradients to capture schizonts or 5% sorbitol to isolate ring-stage parasites.
To establish the techniques in our laboratory, two transfection methods were used in this study. For integration of SNPs, ring stage transfection was performed. Briefly, 3D7 parasites were cultured to approximately 10-15% parasitaemia in 5% haematocrit under standard conditions.
Immediately before transfection, 100 µg of each plasmid (pL6 and pUF1-Cas9) was ethanol-acetate 
Drug Susceptibility Assays.
Synchronised ring stage parasites at 0.5% parasitaemia and 2% haematocrit were exposed to a range of dihydroartemisinin, quinine, chloroquine, lumefantrine, piperaquine, and mefloquine concentrations over a full lifecycle in two biological replicates within 96-well microtitre plates, following standard procedures in our laboratory. Serial two-fold drug dilutions were performed across the plate using complete media; parasites were added thereafter. The plate was incubated at 37°C for 48 hours, freeze-thawed, and drug sensitivity quantitated using SYBR Green fluorescence as described 56 . Parasite survival was normalised between parasites exposed to 10 µM chloroquine and a drug-free control. EC50 estimates were determined using a non-linear regression fit in GraphPad Prism (GraphPad Software, San Diego California USA, version 7.01).
DHA drug-pulse experiments were carried out using our previously published RSA 0-4h
format, 44 itself a modification of the RSA 0-6h of Witkowski et al. 27 and the RSA 0-3h approach of Yang et al.
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. Survival estimates were based on FACS counts performed on live cells using 1:10,000
MitoTracker Deep Red and 1:1,000 SYBR Green (Invitrogen Molecular Probes) stain in PBS. Cells were stained using 8 volumes of stain solution per volume of culture (2% HCT) and analysed on a
LSR-II Flow Cytometer (BD Biosciences). Statistical significance was determined by the two-sample
Wilcoxon rank-sum (Mann-Whitney) test.
Fluorescence Microscopy.
To prepare slides for immunofluorescence microscopy, thin smears were first prepared on glass slides and quickly dried. Sections for staining were marked with a hydrophobic pen. Cells were fixed for 10 minutes with 4% formaldehyde in PBS, washed three times with PBS, permeabilised with 0.1% (v/v) Triton X-100 in PBS for 10 minutes, washed again, and blocked for 1 hour with 3% (w/v) BSA in PBS. Primary antibodies were diluted in PBS containing 3% (w/v) BSA and 0.1% (v/v) Tween20 and incubated on the slide overnight at 4ºC. Slides were again washed several times with PBS and incubated with secondary antibodies diluted in the same buffer. Slides were incubated for 1 hour at room temperature and washed. Glass coverslips were mounted with 1 l of Vectashield with DAPI.
Images were taken on a Nikon TE-100 inverted microscope.
Electron Microscopy.
For ultrastructural analysis, P. falciparum were cultured at 37°C in 4 mL volumes in 6-well tissue culture dishes (Techno Plastic Products) at 2% hematocrit until reaching 6-10% parasitemia. Cultures were synchronized until >80% of parasites were in ring stage growth and then treated for 1 h with 10 nM rapamycin to excise pfap2. Cultures treated with DMSO were used as negative controls.
Parasites were then washed twice with RPMI and incubated at 37°C until harvesting. Synchronised parasites were magnetically sorted in both the trophozoite and the schizont stages by passage through a magnetically mounted MACS LD separation column (Miltenyi Biotech, Germany), collected by centrifugation and fixed in 2% paraformaldehyde/2.5% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM cacodylate buffer, pH 7.2 for 1 h at room temperature. 
Antibodies.
Anti-HA (Roche, 3F10 clone) was obtained commercially. Anti-Clathrin Heavy Chain (rabbit) antibodies were generously donated by Frances Brodsky. We thank Gordon Langsley for making antiRab5B antibodies available. Anti-eIF2a antibodies were generously gifted by William Sullivan.
Pulldown and Mass Spectrometry. University of Dundee Finger-Prints Proteomics facility. Mass spectra were processed using MaxQuant version 1.5, using the intensity-based label-free quantification (LFQ) method 57, 58 .
Minimum peptide length was set at six amino acids and false discovery rates (FDR) of 0.01 were calculated at the levels of peptides, proteins and modification sites based on the number of hits against the reversed sequence database. Ratios were calculated from label-free quantification intensities using only peptides that could be uniquely mapped to a given protein. The software Perseus was used for statistical analysis of the LFQ data 59 .
Disruption of Secretory Traffic with Brefeldin A.
Synchronous wild-type 3D7 cultures were treated with 5 µg/ml BFA or solvent only from hour 2 postinvasion, and a subsequent RSA 4h with 700 nM DHA performed from hours 3 to 7, after which both drug and BFA were washed off, and the parasites returned to drug-free culture to a total of 72 hours post-invasion.
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Plasmodium falciparum malaria in
B Clones of parasite lines expressing AP-2µ(I592T), AP-2µ(I592I), and AP-2µ(S160N) were generated by limiting dilution and confirmed by PCR-RFLP genotype mapping (with SpeI or SnaBI restriction endonuclease) and Sanger sequencing. Amplification of the locus with P1 and P2 produces a 2247 bp fragment; For I592 transgenic parasites, SpeI digestion of an amplicon containing the transgenic locus liberates a 301 bp fragment. The wild-type amplicon is not cleaved. For S160 transgenic parasites, SnaBI does not cleave the transgenic amplicon, while wild-type amplicons liberate a 789 bp fragment. MW: fragment length in kilobases.
C RSA 4h susceptibility to artemisinin (DHA) of mutant and parental parasite lines, presented as percent survival, compared to untreated control, following a 4h pulse of 700 nM dihydroartemisinin. The Cam3.II-family of parasite lines harbour pfkelch13 mutations (as indicated) 13 . Cam3.II REV expresses wild-type pfkelch13. Mean of at least four biological replicates is shown for each line, each performed in technical duplicate, with standard error. Each technical replicate enumerates 100,000 gate-stopping events. P values derived from MannWhitney non-parametric test, comparing each parasite line to 3D7. D EC50 estimates (nM) for clones of each mutant and the 3D7 parent were derived from 48h exposures to the drugs named across a range of concentrations. Each data point shows the mean of at least four biological replicates, performed in technical duplicate, with standard error. Bold face indicates P < 0.05 (Mann-Whitney U test), compared to EC50 estimate for 3D7.
NS: not significant; ***: P < 0.005.
Figure 2. Plasmodium falciparum AP-2µ is localised to a non-canonical cytoplasmic compartment
A Modifications to the homologous repair construct used to install AP-2µ variants (Fig. 1) to fuse a tandem triple haemagglutinin tag (3xHA) onto the C-terminus of AP-2µ.
B PCR-based genotyping of two parasite clones harbouring AP-2µ-3xHA in place of the endogenous AP-2µ allele. Amplification of the integrated transgenic pfap2mu locus with P3 and P2 (annealing sites annotated) produces an 862 bp fragment. Genotypes were confirmed by Sanger sequencing of the PCR products shown.
C Anti-HA western blot confirming expression of the desired fusion protein (approx. 78 kDa) in mixed-stage lysates, compared to wild-type parental 3D7. MW presented in kDa.
D Localisation of AP-2µ-3xHA (green) across the asexual life cycle by anti-HA IFA, counterstained for parasite DNA with DAPI (blue). Images shown are representative of more than 100 cells examined at each stage; merge is the superimposition of each channel on a brightfield image.
E Immunoelectron micrograph of a representative young intra-erythrocytic trophozoite. AP-2µ-3xHA parasites probed with an anti-HA rabbit antibody and a secondary antibody 18 nm gold conjugate. Protein disulphide isomerase (PDI), a marker for the parasite ER, is detected by an anti-PDI mouse antibody and a secondary conjugated to 12 nm gold particles. C: cytostome; N: nucleus; ER: endoplasmic reticulum; White Arrowheads: AP-2µ at nuclear membrane; Black Arrowheads: AP-2µ associated with vesicles; Black Arrows: AP-2µ near the ER. Scale bar: 500 nm.
F Localisation of AP-2µ-3xHA (false-coloured green) with respect to ectopically-expressed GFP-K13 (false-coloured red) across the asexual life cycle by IFA. Representative images of more than 100 observed cells is shown. B Volcano plot for proteins identified by IP in CHAPS buffer. B Volcano plot from p-values versus the corresponding t-test difference of proteins identified by -GFP (nanobody) immunoprecipitation in CHAPS buffer. Cut-off curves for statistically significant interactors (dotted curve) were calculated from the estimated false discovery rate.
C
C Table of abundances and enrichment ratio for subunits of all adaptor protein complex subunits identified in the -CHC-GFP pulldown. ND indicates no peptides were detected that correspond to the listed protein.
D Western blot of -PfCHC immunoprecipitation performed on cryomilled 3D7-AP-2µ-3xHA trophozoite lysates. Membrane was probed with -PfCHC and -HA antibodies.
E Maximum intensity projection IFA of representative trophozoite and schizont stages of 3D7-AP-2µ-3xHA parasites, from among at least 100 cells examined at each stage, probed with both -PfCHC and -HA antibodies, which are red and green in the merge images, respectively.
F Representative maximum intensity projection images of time-lapse live microscopic observation of CHC-2xFKBP-GFP in a trophozoite. Each frame represents the passage of 6 minutes. Suppl. Table 2 . Primers used to screen transgenic lines described in this study Factors identified with greater than 3-fold enrichment in GFP pulldowns compared to control pulldowns with statistical difference between GFP and control pulldowns greater than 0 and at least 2 peptides per protein. ∞ indicates that no peptides were detected in the control pulldown; ND indicates protein was not identified in either the control or HA pulldown. 
